Sign in

Filings

Finds words inside filing documents. Searching Organon & Co.'s filings · 37 documents indexed.

13 documents · 119 matches

  1. OGN Organon & Co. 10-K 2026-02-24

    Item 1A. Risk Factors

    material weaknesses in our internal control over financial reporting. For a description of these material weaknesses, see “Controls and Procedures
    21 matches in this document

  2. OGN Organon & Co. 10-Q 2025-11-10

    Item 1A. Risk Factors

    material weaknesses in the Company’s internal control over financial reporting. For a description of these material weaknesses, see “Controls
    18 matches in this document

  3. OGN Organon & Co. 10-K/A 2025-11-10

    Item 15. Exhibits, Financial Statement Schedules

    material weaknesses described herein. A “material weakness” is a deficiency, or a combination of deficiencies, in internal control over financial
    19 matches in this document

  4. OGN Organon & Co. 10-Q/A 2025-11-10

    Item 6. Exhibits 19

    material weaknesses disclosed in the Form 10-K Amendment and also described herein. A “material weakness” is a deficiency, or a combination
    14 matches in this document

  5. OGN Organon & Co. 10-Q/A 2025-11-10

    Item 6. Exhibits 22

    material weaknesses disclosed in the Form 10-K Amendment, the Q1 Form 10-Q Amendment and also described herein. A “material
    14 matches in this document

  6. OGN Organon & Co. 10-Q 2026-05-04

    Item 4. Controls and Procedures

    material weaknesses as described above. We are actively engaged and have devoted substantial resources towards the implementation of enhanced procedures
    14 matches in this document

  7. OGN Organon & Co. 10-Q 2026-07-31

    Item 4. Controls and Procedures

    material weakness with respect to our tone at the top contributed to an additional material weakness of not maintaining effective
    8 matches in this document

  8. OGN Organon & Co. 8-K 2025-10-27

    Item 8.01. Other Events.

    material weaknesses as of December 31, 2024, as well as any related remediation efforts and corrective disclosures. The Company further
    4 matches in this document

  9. OGN Organon & Co. 8-K 2026-02-12

    material weaknesses in its internal control over financial reporting; the company’s use of artificial intelligence technologies; the company’s ability
    1 match in this document

  10. OGN Organon & Co. 8-K 2026-02-12

    material weaknesses in its internal control over financial reporting; the company’s use of artificial intelligence technologies; the c omp any’s ability
    1 match in this document

  11. OGN Organon & Co. 8-K 2025-11-10

    material weaknesses in internal control over financial reporting and the related costs and management resources in connection therewith, as well
    1 match in this document

  12. OGN Organon & Co. 8-K 2025-11-10

    material weaknesses in internal control over financial reporting and the related costs and management resources in connection therewit h, as well
    1 match in this document

  13. OGN Organon & Co. 8-K 2025-10-27

    material weaknesses. In connection with the investigation, the Company terminated the employment of its Head of U.S. Commercial & Government Affairs
    3 matches in this document

Page 1 of 1 · 13 documents